BNP Paribas Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Sell |
661,082
-42,713
| -6% | -$1.34M | 0.05% | 343 |
|
|
2025
Q1 | $23.6M | Buy |
703,795
+40,091
| +6% | +$1.35M | 0.06% | 297 |
|
|
2024
Q4 | $26M | Buy |
663,704
+224,630
| +51% | +$8.81M | 0.06% | 286 |
|
|
2024
Q3 | $17.3M | Buy |
439,074
+17,953
| +4% | +$707K | 0.04% | 334 |
|
|
2024
Q2 | $16.4M | Buy |
421,121
+4,385
| +1% | +$171K | 0.04% | 331 |
|
|
2024
Q1 | $17.9M | Buy |
+416,736
| New | +$17.9M | 0.05% | 320 |
|